Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 7, 2015; 21(21): 6639-6648
Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6639
Table 1 Baseline characteristics of patients with chronic hepatitis B virus infection
IT (n = 55)IC (n = 67)LR (n = 49)ENH (n = 20)ANOVA P value
Age (yr), median (range)27 (18-55)32 (18-78)40 (21-65)41 (25-65)< 0.001
Gender, n, M/F28/2740/2728/2116/40.160
Log10 HBV DNA,
Log10 (IU/mL), median7.556.983.74.69< 0.001
HBV genotype, n
B34392911
C21282090.960
ALT (U/mL) median16982093< 0.001
AST (U/mL) median13671862< 0.001
HBeAg (S/CO) median1376899NANA< 0.001
PC%, median0.311.739.2033.69< 0.001
BCP%, median1.4215.2543.5867.44< 0.001
Table 2 Correlation between hepatitis B early antigen and clinical parameters
HBeAg status1P valueHBeAg titer2P value
Age (yr)0.0750.357
Log10 HBV DNA (log10 IU/mL)< 0.001< 0.001
ALT (U/L)0.1350.739
PC%0.001< 0.001
BCP%0.552< 0.001
Table 3 Relationship between precore/basal core promoter mutants and clinical parameters
PC%P valueBCP%P value
Age (yr)0.2800.746
Log10 HBV DNA0.4400.723
(log10 IU/mL)
ALT (U/L)0.6550.007
HBeAg titer (S/CO)< 0.001< 0.001